Log In
Tuesday 18th June 2019


FT Health

Babylon’s GP at Hand expands to Birmingham this week

Roll-out to go ahead despite scrutiny over digital health app’s costs and effectiveness

Sanofi/Google: pixel of health

Why the pharma industry has more to gain than lose

Fosun/Bayer: pet project

The effort required does not justify the premium

Google unit reveals data-driven opioid addiction centre

OneFifteen in Dayton aims to collect insights on 1,000 annual outpatient addicts 

Funding cuts to prevention and care threaten NHS plan

Nine in 10 health leaders not confident service will be able to deliver reforms

Pfizer boosts cancer drug portfolio with $11.4bn Array deal

Venture is latest move in race between pharmaceutical groups for oncology businesses

Government accused of ‘jumping the gun’ on NHS pension changes

Health secretary pre-empts findings of own advisory board on controversial proposals

Poor countries pay up to 30 times more for medicines

Nations urged to buy more unbranded generics to lower healthcare costs

Namal Nawana: Sending shockwaves through Smith & Nephew

Medical devices group gets new lease of life under dealmaking veteran

Drugmakers sue over rule requiring prices in TV ads

Amgen, Merck and Eli Lilly say Trump administration’s move infringes on free speech

Bluebird Bio prices gene therapy at nearly $1.8m

Boston-based biotech start-up will only seek full payment if the treatment works

Hansoh Pharma soars on Hong Kong stock market debut

Hansoh IPO creates China’s richest couple

Founder and husband’s $17bn wealth topples Baidu’s Robin Li and wife from rich list

Can bluetooth headsets alleviate depression and insomnia?

Brain Machine Interfaces are wearable tech that probe the brain’s electrical circuitry

China pharma/Hansoh IPO: class act

Generic drug company founded by chemistry teacher is set for straight-A success

GSK links up with US university on genome research

Drugmaker will fund 20 scientists in rare partnership with University of CaliforniaS

Digital health breakthrough as US insurers agree to pay for insomnia app

Deal with CVS Health means digital treatment can be paid for in same way as sleeping pills

Insys bankruptcy sets up opioid fight with US states

Lawyers for 1,800 plaintiffs vow to ‘actively pursue’ drugmakers regardless of Chapter 11 filing

Opioid maker Insys files for Chapter 11 bankruptcy

Group buckles under weight of legal liabilities in wake of US addiction crisis

AI study in London offers hope for MS treatment

Researchers use computer algorithms to track changes in hundreds of MRI brain scans

Regulators hold up Roche’s $5bn Spark acquisition

Wait period extended after watchdogs in US and UK request more information about deal

Doctors warn of NHS workforce ‘crisis’ over pension tax rules

Consultants refusing to take on extra work for fear of busting new limitations

UK biotechs seek to speed up cancer detection

Small-cap groups battle to develop new technologies that could save lives

Sanofi appoints top Novartis executive as new chief

Paul Hudson, who ran Swiss group’s pharmaceuticals business, will take over in September

Smiths Group names medical chief as it pushes ahead with spin off

Division to become a separate UK-listed company by mid-2020

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019